Nutex Health, Inc. ownership disclosure: Pertento Partners LLP, Pertento Advisors LLC and Eduardo Marques each report 361,988 shares of Common Stock, 5.2% of the class, as reported in the Schedule 13G. The filing states these securities are directly owned by advisory clients of Pertento Partners LLP. The reporting persons signed a Joint Filing Agreement.
Positive
None.
Negative
None.
Insights
Large passive stake reported by advisory entities and principal.
Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques each report 361,988 shares (5.2%) of Common Stock. The filing lists shared voting and dispositive power of 361,988 for each reporting person.
The filing states the shares are directly owned by advisory clients; cash-flow treatment and trading intent are not disclosed. Subsequent filings may clarify whether these holdings are passive or part of coordinated activity.
Joint filing and disclaimer indicate coordinated reporting, not necessarily beneficial control.
The report includes a Joint Filing Agreement and a signed disclaimer stating each reporting person disclaims beneficial ownership except to the extent of pecuniary interest. Item 6 explains securities are owned by advisory clients of Pertento Partners LLP.
Voting/dispositive powers are reported as shared. Monitor future disclosures for any Section 13(d) activity or changes in ownership percentages.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Nutex Health, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
03/05/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Pertento Partners LLP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED KINGDOM
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
361,988.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
361,988.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
361,988.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Pertento Advisors LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
361,988.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
361,988.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
361,988.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Eduardo Marques
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
BRAZIL
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
361,988.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
361,988.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
361,988.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Nutex Health, Inc.
(b)
Address of issuer's principal executive offices:
1776 Yorktown St., Suite 700, Houston, Texas 77056
Address or principal business office or, if none, residence:
Pertento Partners LLP
111 Park Street
London W1K7JL
United Kingdom
Pertento Advisors LLC
111 Park Street
London W1K7JL
United Kingdom
Eduardo Marques
111 Park Street
London W1K7JL
United Kingdom
(c)
Citizenship:
Pertento Partners LLP - United Kingdom
Pertento Advisors LLC - Delaware
Eduardo Marques - Brazil
(d)
Title of class of securities:
Common Stock, $0.001 par value
(e)
CUSIP No.:
67079U306
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G are directly owned by advisory clients of Pertento Partners LLP. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Pertento Partners LLP
Signature:
By: /s/ Eduardo Marques
Name/Title:
Eduardo Marques, Managing Partner
Date:
03/10/2026
Pertento Advisors LLC
Signature:
By: /s/ Eduardo Marques
Name/Title:
Eduardo Marques, Authorized Person
Date:
03/10/2026
Eduardo Marques
Signature:
By: /s/ Eduardo Marques
Name/Title:
Eduardo Marques
Date:
03/10/2026
Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
What stake does Pertento report in Nutex Health (NUTX)?
Pertento reports 361,988 shares, representing 5.2% of Nutex Health common stock. The Schedule 13G lists identical share and percentage amounts for Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques.
Who actually owns the shares reported by Pertento?
The filing states the securities are directly owned by advisory clients of Pertento Partners LLP. The reporting persons disclaim beneficial ownership beyond their pecuniary interest, per the Schedule 13G and Item 6 disclosure.
Do the reporting parties have voting or dispositive power over the shares?
Each reporting person is shown with shared voting power and shared dispositive power of 361,988 shares. Sole voting and sole dispositive powers are reported as 0 for each.
Are these holdings reported as passive or active under Schedule 13G?
The filing is a Schedule 13G, which is used for passive investors; the document does not state trading intent or activist plans. The form and disclosed advisory-client ownership indicate a passive reporting posture.
Did the reporting persons sign any agreement when filing?
Yes. The submission includes a Joint Filing Agreement and is signed by Eduardo Marques with signature dates shown as 03/10/2026 in the provided excerpt.
